Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Smith & Nephew executives offload shares

(Sharecast News) - Medical technology company Smith & Nephew disclosed two executive share sales on Wednesday, with its shares remaining flat after the announcement. Phil Cowdy, its chief corporate development and corporate affairs officer, sold 12,083 shares on 27 April for £12.83280 each, resulting in a total value of £155,058.72.

Following the sale, Cowdy still held 49,000.99390 ordinary shares, equivalent to 0.00558% of its issued share capital.

Bradley Cannon, the company's president of global orthopaedics, meanwhile sold 9,500 shares on 2 May at a price of £12.926813 apiece, resulting in a total value of £122,804.72.

After the transaction, Cannon still held 117,819.37494 shares, or 0.01342% of the firm's issued capital.

Both individuals still maintained a shareholding in line with the company's guidelines after the sale, the board confirmed.

Elsewhere, NB Private Equity Partners saw its shares rise after non-executive director Trudi Clark made a small share purchase.

Clark purchased 1,247 shares at a price of 15.9p, for a total value of £19,827.30.

At 1427 BST, shares in Smith & Nephew were flat at 1,298p, while those in NB Private Equity Partners were up 1.69% at 120p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Director dealings: Halma CEO makes share sale
(Sharecast News) - Halma revealed on Monday that chief executive Marc Ronchetti had disposed of 47,000 ordinary shares in the FTSE 100-listed safety equipment company.
Director dealings: Next CEO sells shares after guidance upgrade
(Sharecast News) - Next chief executive Simon Wolfson, also known as Lord Wolfson of Aspley Guise, sold 20,272 shares in the retailer at 15,688.57p each for just over £3.1m.
Director dealings: Cadence Minerals CEO raises stake
(Sharecast News) - Cadence Minerals revealed on Thursday that chief executive Kiran Morzaria had acquired 733,867 ordinary shares in the AIM-listed investment and development firm.
Director dealings: Chemring CEO lowers stake
(Sharecast News) - Chemring revealed on Wednesday that chief executive Michael Ord had disposed of 200,000 ordinary shares in the FTSE 250-listed defense technology company.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.